Novo Nordisk A/S (NVO) Wins U.S. Wegovy Approval for MASH, Expands to China Market
Tuesday, 2 September 2025 ()
We recently compiled a list of the 11 Best Pharma Stocks to Invest in for the Long Term. Novo Nordisk A/S is one of them. Novo Nordisk A/S (NYSE:NVO), a global pharmaceutical leader in diabetes and obesity care, continues to strengthen its position with new clinical data, expanded marketβ¦
|
||||
You Might Like |
||||
